TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy

[1]  Jaime Grutzendler,et al.  Attenuation of β-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity , 2016, The Journal of Neuroscience.

[2]  Mariana Vargas-Caballero,et al.  Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology , 2016, Brain : a journal of neurology.

[3]  S. Younkin,et al.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.

[4]  Keith A. Johnson,et al.  Modulation of TREM2 by CD33: a protein QTL study integrates Alzheimer loci in human monocytes , 2015, Nature Neuroscience.

[5]  O. Korvatska,et al.  R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study. , 2015, JAMA neurology.

[6]  A. Najafi,et al.  Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice , 2015, Journal of Neuroinflammation.

[7]  P. De Camilli,et al.  Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer’s disease amyloid plaques , 2015, Proceedings of the National Academy of Sciences.

[8]  J. Herms,et al.  Fibrillar Amyloid Plaque Formation Precedes Microglial Activation , 2015, PloS one.

[9]  R. Ransohoff,et al.  TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models , 2015, The Journal of experimental medicine.

[10]  D. Holtzman,et al.  TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.

[11]  F. Edwards,et al.  A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. , 2015, Cell reports.

[12]  J. Grutzendler,et al.  Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques , 2014, Nature Communications.

[13]  L. Lue,et al.  TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post‐Mortem Temporal Cortices , 2014, Brain pathology.

[14]  B. Vissel,et al.  Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease , 2014, Acta neuropathologica communications.

[15]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[16]  A. Goate,et al.  Coding variants in TREM2 increase risk for Alzheimer's disease. , 2014, Human molecular genetics.

[17]  D. Holtzman,et al.  Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2 , 2014, Molecular Neurodegeneration.

[18]  J. Herms,et al.  In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques , 2014, Acta neuropathologica communications.

[19]  M. Bullido,et al.  Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia , 2014, Neurobiology of Aging.

[20]  Carol J Hirschmugl,et al.  Synchrotron FTIR reveals lipid around and within amyloid plaques in transgenic mice and Alzheimer's disease brain. , 2013, The Analyst.

[21]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[22]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[23]  H. Kretzschmar,et al.  Amyloid plaque formation precedes dendritic spine loss , 2012, Acta Neuropathologica.

[24]  Douglas G. Walker,et al.  Postmortem interval effect on RNA and gene expression in human brain tissue , 2011, Cell and Tissue Banking.

[25]  Jamaal A Rehman,et al.  TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[26]  J. Grutzendler,et al.  Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition , 2011, Scientific reports.

[27]  J. Grutzendler,et al.  CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis , 2010, The Journal of Neuroscience.

[28]  G. Landreth,et al.  The role of microglia in amyloid clearance from the AD brain , 2010, Journal of Neural Transmission.

[29]  K. Coggeshall,et al.  TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1 , 2010, Science Signaling.

[30]  David Baddeley,et al.  Visualization of Localization Microscopy Data , 2010, Microscopy and Microanalysis.

[31]  G. Landreth,et al.  CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation , 2009, The Journal of Neuroscience.

[32]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[33]  David Baddeley,et al.  Light-induced dark states of organic fluochromes enable 30 nm resolution imaging in standard media. , 2009, Biophysical journal.

[34]  I. Bechmann,et al.  TREM2 is upregulated in amyloid plaque‐associated microglia in aged APP23 transgenic mice , 2008, Glia.

[35]  D. Westaway,et al.  Dense-core and diffuse Abeta plaques in TgCRND8 mice studied with synchrotron FTIR microspectroscopy. , 2007, Biopolymers.

[36]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[37]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[38]  Hartwig Wolburg,et al.  Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology , 2006, EMBO reports.

[39]  W. Gan,et al.  ATP mediates rapid microglial response to local brain injury in vivo , 2005, Nature Neuroscience.

[40]  J. Dietschy,et al.  Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.

[41]  K. Moore,et al.  CD36 Mediates the Innate Host Response to β-Amyloid , 2003, The Journal of experimental medicine.

[42]  M. Colonna.  TREMs in the immune system and beyond , 2003, Nature Reviews Immunology.

[43]  J. Sutcliffe,et al.  Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia , 2002, Journal of neurochemistry.

[44]  M. Staufenbiel,et al.  3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid , 2001, Neurobiology of Aging.

[45]  B. Blom,et al.  DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. , 2000, Immunity.

[46]  Leena Peltonen,et al.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts , 2000, Nature Genetics.

[47]  W. B. Stine,et al.  The nanometer-scale structure of amyloid-Β visualized by atomic force microscopy , 1996 .

[48]  J. Reed,et al.  Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. , 1992, Journal of molecular biology.

[49]  G. Kuperminc,et al.  Acknowledgments , 1991, European Journal of Psychology of Education.

[50]  Habib Zaidi,et al.  Amyloid-β positron emission tomography imaging probes: a critical review. , 2013, Journal of Alzheimer's disease : JAD.

[51]  A. Singleton,et al.  TREM2 Variants in Alz hei mer's Disease , 2012 .

[52]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[53]  W. B. Stine,et al.  The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy. , 1996, Journal of protein chemistry.